Quoin pharmaceuticals to report third quarter 2022 financial results and provide corporate update on november 10th

Ashburn, va., nov. 01, 2022 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its third quarter 2022 financial results will be reported on thursday, november 10, 2022 before the open of the financial markets. management will also host a webcast and conference call on november 10, 2022 at 8:30 a.m. et to discuss the results and provide a corporate update.
QNRX Ratings Summary
QNRX Quant Ranking